Cachet Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	2,108	2,223	2,885	2,184	2,338	2,019
Trading Asset Securities	0.15	0.17	0.14	0.16	0.23	-
Cash & Short-Term Investments	2,108	2,223	2,886	2,184	2,338	2,019
Cash Growth	-2.60%	-22.95%	32.14%	-6.61%	15.85%	28.04%
Accounts Receivable	6,151	7,171	9,205	8,885	8,039	7,840
Other Receivables	69.82	82.7	331.79	390.51	113.61	94.16
Receivables	6,221	7,254	9,537	9,276	8,153	7,934
Inventory	2,650	2,739	2,562	2,692	2,185	2,014
Other Current Assets	711.69	788.03	646.38	843.66	609.02	601.16
Total Current Assets	11,691	13,005	15,631	14,996	13,285	12,567
Property, Plant & Equipment	414.86	465.38	679.74	735.93	850.26	795.53
Long-Term Investments	1.87	1.87	1.74	2.44	2.53	2.45
Goodwill	395.45	395.45	475.86	515.92	562.38	576.09
Other Intangible Assets	24.68	24.45	35.58	35.79	36.58	31
Long-Term Accounts Receivable	-	3.56	27.32	33.56	-	-
Long-Term Deferred Tax Assets	92.21	73.03	92.97	68.15	52.57	56.36
Long-Term Deferred Charges	54.48	63.45	171	144.35	122.8	98.27
Other Long-Term Assets	5.67	5.85	6.1	24.89	25.14	6.85
Total Assets	12,680	14,038	17,121	16,557	14,938	14,134
Accounts Payable	3,972	4,474	5,858	5,320	4,442	4,094
Accrued Expenses	77.66	131.73	71.42	53.81	62.23	70.82
Short-Term Debt	1,919	2,678	3,882	4,112	4,002	3,857
Current Portion of Leases	20.43	58.17	54.89	49.7	58.16	44.47
Current Income Taxes Payable	64.36	42.93	82.2	71.29	60.31	77.87
Current Unearned Revenue	182.96	186.31	433.63	291.82	309.06	345.07
Other Current Liabilities	216.48	271.28	467.01	517.26	87.43	106.77
Total Current Liabilities	6,453	7,842	10,849	10,415	9,022	8,596
Long-Term Leases	130.61	130.09	175.95	208.76	229.24	176.06
Long-Term Deferred Tax Liabilities	2.23	0.76	4.3	11.24	29.95	37.26
Total Liabilities	6,586	7,973	11,029	10,635	9,281	8,810
Common Stock	291.71	291.71	291.71	291.71	291.71	291.71
Additional Paid-In Capital	1,292	1,292	1,291	1,291	1,288	1,288
Retained Earnings	2,835	2,743	2,658	2,495	2,306	2,049
Total Common Equity	4,418	4,327	4,241	4,078	3,887	3,629
Minority Interest	1,676	1,738	1,851	1,844	1,770	1,695
Shareholders' Equity	6,095	6,065	6,092	5,922	5,657	5,324
Total Liabilities & Equity	12,680	14,038	17,121	16,557	14,938	14,134
Total Debt	2,070	2,866	4,113	4,370	4,290	4,077
Net Cash (Debt)	38.66	-642.37	-1,227	-2,186	-1,951	-2,059
Net Cash Per Share	0.13	-2.20	-4.22	-7.51	-6.67	-7.07
Filing Date Shares Outstanding	291.71	291.71	291.71	291.71	291.71	291.71
Total Common Shares Outstanding	291.71	291.71	291.71	291.71	291.71	291.71
Working Capital	5,238	5,163	4,781	4,581	4,263	3,971
Book Value Per Share	15.15	14.83	14.54	13.98	13.32	12.44
Tangible Book Value	3,998	3,907	3,729	3,526	3,288	3,022
Tangible Book Value Per Share	13.71	13.39	12.78	12.09	11.27	10.36
Buildings	-	273.07	273.07	273.07	273.07	273.07
Machinery	-	247.57	882.53	797.4	723.89	598.65
Construction In Progress	-	1.09	-	1.56	5.08	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.